OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
An Ionizable Lipid Material with a Vitamin E Scaffold as an mRNA Vaccine Platform for Efficient Cytotoxic T Cell Responses
Ryotaro Oyama, Harumichi Ishigame, Hiroki Tanaka, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 18758-18774
Open Access | Times Cited: 17
Ryotaro Oyama, Harumichi Ishigame, Hiroki Tanaka, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 18758-18774
Open Access | Times Cited: 17
Showing 17 citing articles:
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Man Wang, Fei Yu, Yuan Zhang
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Exploring the immuno-nano nexus: A paradigm shift in tumor vaccines
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Yuanyuan Li, Yuxing Xu, Wenwen Su, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117897-117897
Closed Access | Times Cited: 1
Hierarchical Chitin Nanocrystal-Based 3D Printed Dual-Layer Membranes Hydrogels: A Dual Drug Delivery Nano-Platform for Periodontal Tissue Regeneration
Danilo M. dos Santos, Jae-I Moon, Da‐Seul Kim, et al.
ACS Nano (2024) Vol. 18, Iss. 35, pp. 24182-24203
Closed Access | Times Cited: 6
Danilo M. dos Santos, Jae-I Moon, Da‐Seul Kim, et al.
ACS Nano (2024) Vol. 18, Iss. 35, pp. 24182-24203
Closed Access | Times Cited: 6
mRNA vaccine designs for optimal adjuvanticity and delivery
Yuki Mochida, Satoshi Uchida
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-27
Open Access | Times Cited: 5
Yuki Mochida, Satoshi Uchida
RNA Biology (2024) Vol. 21, Iss. 1, pp. 1-27
Open Access | Times Cited: 5
Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Nonviral targeted mRNA delivery: principles, progresses, and challenges
Xi He, Guohong Li, Li-Hsin Huang, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Xi He, Guohong Li, Li-Hsin Huang, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Low-inflammatory lipid nanoparticles facilitate safe mRNA vaccination against influenza virus infection
Yuehua Xu, Guangxi Zhai, Dapeng Yang, et al.
Molecular Therapy (2025)
Closed Access
Yuehua Xu, Guangxi Zhai, Dapeng Yang, et al.
Molecular Therapy (2025)
Closed Access
Control of the Particle Trafficking and Dynamics of the Lymphatic System and of the Cellular Microenvironment
Hiroki Tanaka, Hidetaka Akita
(2025), pp. 39-52
Open Access
Hiroki Tanaka, Hidetaka Akita
(2025), pp. 39-52
Open Access
The Effect of Cholesterol Content on the Adjuvant Activity of Nucleic-Acid-Free Lipid Nanoparticles
Jessica Anindita, Hiroki Tanaka, Takuma Yamakawa, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 181-181
Open Access | Times Cited: 3
Jessica Anindita, Hiroki Tanaka, Takuma Yamakawa, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 181-181
Open Access | Times Cited: 3
Innate and Adaptive Immune Parameters following mRNA Vaccination in Mice
Srinivasa Reddy Bonam, Nicholas Hazell, Mano Joseph Mathew, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 543-543
Open Access | Times Cited: 3
Srinivasa Reddy Bonam, Nicholas Hazell, Mano Joseph Mathew, et al.
Vaccines (2024) Vol. 12, Iss. 5, pp. 543-543
Open Access | Times Cited: 3
Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy
Jacob Witten, Idris O. Raji, Rajith S. Manan, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 3
Jacob Witten, Idris O. Raji, Rajith S. Manan, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 3
Current landscape of mRNA technologies and delivery systems for new modality therapeutics
Ruei‐Min Lu, Hsiang-En Hsu, Ser John Lynon P Perez, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Ruei‐Min Lu, Hsiang-En Hsu, Ser John Lynon P Perez, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 1
mRNA vaccines as cancer therapies
Shaoxiong Huang, Haiying Que, Manni Wang, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
Shaoxiong Huang, Haiying Que, Manni Wang, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 1
Development of a Ready-to-Use-Type RNA Vaccine Carrier Based on an Intracellular Environment-Responsive Lipid-like Material with Immune-Activating Vitamin E Scaffolds
Jessica Anindita, Hiroki Tanaka, Ryotaro Oyama, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2702-2702
Open Access | Times Cited: 3
Jessica Anindita, Hiroki Tanaka, Ryotaro Oyama, et al.
Pharmaceutics (2023) Vol. 15, Iss. 12, pp. 2702-2702
Open Access | Times Cited: 3
1mΨ influences the performance of various positive-stranded RNA virus-based replicons
Paola Miyazato, Takafumi Noguchi, Fumiyo Ogawa, et al.
Research Square (Research Square) (2024)
Open Access
Paola Miyazato, Takafumi Noguchi, Fumiyo Ogawa, et al.
Research Square (Research Square) (2024)
Open Access
1mΨ influences the performance of various positive-stranded RNA virus-based replicons
Paola Miyazato, Takafumi Noguchi, Fumiyo Ogawa, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Paola Miyazato, Takafumi Noguchi, Fumiyo Ogawa, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Enhanced Broad-Spectrum Efficacy of an L2-Based mRNA Vaccine Targeting HPV Types 6, 11, 16, 18, with Cross-Protection Against Multiple Additional High-Risk Types
Kosuke Tsukamoto, Akio Yamashita, Masatoshi Maeki, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1239-1239
Open Access
Kosuke Tsukamoto, Akio Yamashita, Masatoshi Maeki, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1239-1239
Open Access
